Statistics

Total Visits

Views
A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results40

Select a period of time:

Number of views in the range

Views
A cohort compassionate-use program with cabazitaxel plus prednisone for patients with metastatic castration-resistant prostate cancer: Interim results24

Views

Views
September 20242
October 20243
November 20246
December 20241
January 20252
February 20253
March 20257
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States15
Singapore7
United Kingdom2
 

Top cities views

Views
Santa Clara4